Chinese Biotech Funding Rebounds As $100m VC/PE Deals Return

 
• By Dexter Jie Yan

AI specialist METiS Pharmaceuticals raked in $100m in a series C round, while four other deals backed by venture capital and private equity firms crossed the CNY100m ($14m) mark in the latest fundraisings by Chinese biopharma companies.

funding
METiS brought in first $100m funding in months for Chinese ventures • Source: Shutterstock

More from China

More from Focus On Asia